Natural Capsules Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Natural Capsules Ltd. on BSE

Search Inside the pdf :

Natural Capsules Ltd.

22 May 2025

203.35

-0.80%

Board Meeting

Natural Capsules Ltd - 524654 - Board Meeting Intimation for 166Th Meeting Of The Board Of …

BSE India

Natural Capsules Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve 1.Audited Consolidated & Standalone Financial Results of the company for theQuarter & Financial Year ended March 31st 2025 2.Any other matters with the permission of the Chairman. We request you to kindly take the aforesaid information on record for dissemination through your website

pdf

Natural Capsules Ltd.

07 May 2025

203.35

-0.80%

Company Update

Natural Capsules Ltd - 524654 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance …

BSE India

In compliance with provisions of Regulation 30 of LODR, we would like to inform that Mrs. Shilpa Burman has tendered resignation from the post of Company Secretary & Compliance Officer with effect from May 07, 2025. The required details are enclosed herewith.

pdf

Natural Capsules Ltd.

02 May 2025

203.35

-0.80%

Corp. Note

Natural Capsules Ltd - 524654 - Format of the Annual Disclosure to be made by an …

BSE India

Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Natural Capsules Ltd 2 CIN NO. L85110KA1993PLC014742 3 Report filed for FY 2024-2025 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* 2024-25,2025-26 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) Not Applicable 8Quantum of (d), which has been met from (c)(e)* Not Applicable 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* Not Applicable Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)2023-24,2024-25 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Shilpa Burman Designation :-Compliance officer and company secretary Name of the Chief Financial Officer :- Raj Kishore Prasad Designation : -Chief Financial Officer Date: 02/05/2025

pdf

Natural Capsules Ltd.

21 Apr 2025

203.35

-0.80%

Corp. Note

Natural Capsules Ltd - 524654 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyNatural Capsules Ltd 2CIN NO.L85110KA1993PLC014742 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 25.43 4Highest Credit Rating during the previous FY BBB 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)ICRA LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Shilpa Burman Designation: Company Secretary and Compliance Officer EmailId: company.sec@naturalcapsules.com Name of the Chief Financial Officer: Raj Kishore Prasad Designation: Chief Financial Officer EmailId: rk.prasad@naturalcapsules.com Date: 21/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Natural Capsules Ltd.

09 Apr 2025

203.35

-0.80%

Company Update

Natural Capsules Ltd - 524654 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Pursuant to Regulation 74(5) of SEBI (DP) Regulations, 2018, we submit herewith certificate received from M/s Cameo Corporate Services Limited, RTA for the quarter ended 31.03.2025.

pdf

Natural Capsules Ltd.

27 Mar 2025, 03:57PM

203.35

-0.80%

SAST

Natural Capsules Ltd - 524654 - Closure of Trading Window

BSE India

Pursuant to SEBI(Prohibition of Insider Trading) Regulations, 2015 and the Company''s code of conduct for prevention of Insider Trading and code of Corporate Disclosure Practices, we wish to inform that Trading window for dealing in equity shares of the Company, shall remain closed for all Designated Persons and their immediate relatives with effect from 01.04.2025 till the conclusion of 48 hours after the declaraation of financial results of the Company for the quarter and financials year ended 31st March, 2025.

pdf

Natural Capsules Ltd.

13 Feb 2025

203.35

-0.80%

Company Update

NATURAL CAPSULES LTD. - 524654 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find enclosed herewith newspaper ad in connection with unaudited financial results for the period ended 31.12.2024.

pdf

Natural Capsules Ltd.

12 Feb 2025

203.35

-0.80%

Company Update

NATURAL CAPSULES LTD. - 524654 - Intimation For Listing Of Shares Of The Company On NSE

BSE India

We wish to inform that we have received approval letter from NSE. As per the approval, the equity shares of the company shall be listed and admitted for dealings on the Exchange (NSE) w.e.f. February 14, 2025. A copy of NSE approval letter is enclosed for reference.

pdf

Natural Capsules Ltd.

12 Feb 2025

203.35

-0.80%

Company Update

NATURAL CAPSULES LTD. - 524654 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Please find enclosed herewith copy of Press Release in connection with unaudited consolidated and standalone financial results for the quarter ended 31.12.2024.

pdf

Natural Capsules Ltd.

12 Feb 2025

203.35

-0.80%

Investor Presentation

NATURAL CAPSULES LTD. - 524654 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Please find enclosed herewith copy of investors presentation in connection with unaudited standalone and consolidated financials for the quarter ended 31.12.2024.

pdf

Is Natural Capsules Ltd. worth buying?

42 Votes:

Buy 85.71%

Sell 11.9%

Hold 2.38%